-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
Meeting News
-
WCLC Chairs Welcome Opportunity to Gather Face-to-Face
Challenges remain throughout the world, but the 2022 World Conference on Lung Cancer chairs say the extra effort required to find solutions is worth it.
-
Journal of Thoracic Oncology Impact Factor Surpasses 20
A journal’s impact factor reflects the yearly number of citations of its recently published articles. JTO’s impact factor has consistently grown for the past several years.
-
Step It Up For Research!
Join IASLC’s first annual steps challenge and raise money for cancer research while staying active during WCLC 2022.
-
Foundation Announces 2022 Young Investigator Grant Recipients
The International Lung Cancer Foundation recently awarded $350,000 in grants to support lung cancer research and young investigators.
-
Workshops Offer Opportunities for Education, Networking Based on Shared Interests, Specialties
WCLC 2022 will kick-off with several sessions designed to give specialty audiences more interaction with experts and thought leaders.
-
In Brief for June 22, 2022
See the latest IASLC meeting news, including an extended deadline for ACLC abstract submissions and COVID-19 guideline updates for those traveling to WCLC.
-
In Brief for June 8, 2022
Abstract submission deadlines are approaching for the Asia Conference on Lung Cancer and the North America Conference on Lung Cancer.
-
Panel Explores Emerging Treatments and Sequencing Strategies for Patients with Advanced NSCLCs Driven by Rare Oncogenes
During the 2022 European Lung Cancer Congress, experts reviewed evidence on drugs targeting MET exon 14 skipping mutations and RET, HER2, and BRAF alterations.
-
Evidence Supports Adding Biological, Pathological, and Molecular Assessments to the TNM Lung Cancer Staging System
A presentation at the 2022 European Lung Cancer Congress convinced attendees that the current system for staging lung cancer needs refinement.
-
Renowned Researcher Fred Hirsch Delivers 2022 Heine H. Hansen Award Lecture
The honor of giving the opening keynote address during ELCC recognizes Dr. Hirsch’s significant contributions to international research and education.